9th Zurich Immuno-Oncology Symposium

Подробнее о видео

The 9th Zurich Immuno-Oncology Symposium brought together leading experts at University Hospital Zurich to discuss the latest advancements in CAR-T therapies, gene editing, bispecific antibodies, and next-generation immunotherapies.

International and local speakers shared insights on precision medicine, tumor microenvironments, and novel cell therapies. You can now rewatch those talks.
Please note: Some talks are not available due to unpublished data.

00:00 – 05:28 Opening Remarks by Markus G. Manz
05:28 – 31:41 Pietro Genovese – Advanced Genetic Engineering to Improve Cancer Adaptive Immunotherapy
31:41 – 01:01:03 Christos Georgiadis – Genome-Edited "Universal" CAR T Cells for Childhood Leukaemia
01:01:03 – 01:33:29 Sai Reddy – Engineering T Cell Specificity and Function for Cancer Immunotherapy
01:33:29 – 01:44:04 Chiara F. Magnani – Acquisition of an Immunosuppressive Microenvironment After CAR-T Therapy Drives T-Cell Dysfunction and Resistance (some slides blacked out)
01:44:04 – 02:05:19 John B.A.G. Haanen – CLAUDIN-6 CAR-T +/- CarVac in Refractory Solid Cancers
02:05:19 – 02:16:44 Christian Pellegrino – Adaptor CAR T-Cells in Solid Tumors
02:16:44 – 02:42:49 Nico Lachmann – From Regenerative Medicine to Anti-Cancer Therapies: iPSC-Derived CAR-Macrophages
02:42:49 – 03:06:40 Evelyn Ullrich – CAR-NK Cell Therapy: Current Status and Future Perspectives
03:06:40 – 03:31:17 Helmut Salih – Bispecific Antibodies in Solid Tumors
03:31:17 – 03:56:18 Heinz Läubli – Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes (TIL)
03:56:18 – 04:21:51 Marjolein van Egmond – Including Neutrophils in Anti-Cancer Therapy
04:21:51 – 04:46:53 Antonia Rotolo – CAR-iNKT Immunotherapy
04:46:53 – 05:15:26 Andreas Plückthun – Precision Gene Delivery for Tumor Therapy
05:15:26 – 05:49:13 Christian Klein – The Present and Future of Bispecific Antibodies for Cancer Therapy
05:49:13 – 06:03:51 Mitch Levesque – Predicting Therapeutic Responses to Immunotherapy in Melanoma and Preventing irAEs
06:03:51 Markus G. Manz – Closing Remarks